The FDA has published a compliance policy guide for implementing feasibility studies and pilot programs for radio frequency identification (RFID) technology to deter counterfeiting and diversion. The agency has also created an internal RFID Workgroup to monitor the adoption of RFID technology in the prescription drug supply chain. (For more on RFID )